RESEARCHERS believe four cancer-fighting drugs may also work in treating rheumatoid arthritis.
In an exciting discovery, a team of international scientists has uncovered new regions of DNA involved in rheumatoid arthritis, identifying genes which are known to be the targets of already approved chemotherapy drugs.
University of Queensland Diamantina Institute director Matthew Brown, who was involved in the research, said it paved the way for human trials of new treatments for rheumatoid arthritis, a painful, debilitating condition caused by immune system dysfunction.
Professor Brown said the study, to be published in the prestigious journal Nature , showed how genetic research could be used to find potential new treatments for diseases among existing drugs, getting medications to patients earlier.
“It short-cuts by many years the time taken between the genetic research and clinical trials,” he said. “For existing drugs, there’s no toxicology testing required, no extra studies needed to look at safety before you can think about doing trials in humans because they’ve already been done.
“It takes 10 years off the process of developing drugs and greatly reduces the cost.”
Professor Brown said genetics had made huge inroads into finding the causes of common diseases in the past decade.
“This study shows one way forward that will turn those discoveries much more rapidly into treatments, which is what we all strive for in research,” he said.
The researchers identified 48 new genes as the most likely culprits in the development of rheumatoid arthritis, nearly doubling the number known to be involved.
About 65 per cent of a person’s risk for the disease is believed to be genetic, with environmental factors also implicated. For example, smoking is a known trigger in genetically susceptible people.
It affects about one in 100 people and is more common in women, than men.
The Latest on: Rheumatoid arthritis
via Google News
The Latest on: Rheumatoid arthritis
- Arthritis: People with arthritis may be twice as likely to develop a problem in the mouthon August 10, 2022 at 2:17 am
WHEN it comes to arthritis most of us think of inflamed and painful joints that make everyday activities difficult. However, it can also have an unexpected effect - on the mouth.
- Arthritis striking early, children becoming victimson August 9, 2022 at 6:44 pm
BENGALURU: Doctors are witnessing early onset of arthritis or rheumatoid arthritis or juvenile idiopathic arthritis (JIA) among children, even among kids as young as six months to 16-year-olds. If not ...
- Cancer, arthritis patients struggling to get medicine after abortion rulingon August 8, 2022 at 2:00 pm
Methotrexate and misoprostol treat a number of medical conditions but can impact pregnancy, so some doctors, pharmacies say no to a prescription.
- Plaque psoriasis and psoriatic arthritis: trials to watch in 2022on August 8, 2022 at 9:40 am
Four Phase II and III trials in plaque psoriasis or psoriatic arthritis have results expected in 2H 2022, and five Phase III studies have expected completions.
- Abortion bans complicate access to drugs for cancer, arthritis, even ulcerson August 8, 2022 at 7:31 am
Medicines that treat conditions from cancer to autoimmune diseases to ulcers can also end a pregnancy or cause birth defects. As a result, doctors and pharmacists in more than a dozen states with ...
- Global Rheumatoid Arthritis Market Development Status, Business Growth and Regional Forecast To 2026on August 8, 2022 at 7:20 am
According to the industry analysis report titled 'Global Rheumatoid Arthritis Market (2021 Edition) – Analysis ...
- Haqqani: How rheumatoid arthritis affects the hearton August 8, 2022 at 6:01 am
Rheumatoid arthritis occurs when the body’s immune system overreacts and attacks healthy cells when it should be fighting unhealthy ones. The joints are most vulnerable to RA and often, many joints ...
- Eating fish and seafood reduces risk of rheumatoid arthritison August 4, 2022 at 7:44 pm
Rheumatoid arthritis (RA) is one of the most commonly occurring illnesses in women and affects about 1% of the world’s population. This autoimmune disease causes chronic and systemic inflammation in ...
- Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RAon August 4, 2022 at 1:06 pm
Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the launch of a prospective clinical study designed to validate a novel and minimally invasive genomic ...
- Women report losing access to crucial arthritis medication, methotrexate, due to state abortion banson August 3, 2022 at 2:00 am
Women of childbearing age report losing access to the arthritis medication methotrexate in states with abortion bans after the Supreme Court ruling.
via Bing News
